drugset / Trial / NCT00680134

Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis

NCT00680134

Phase 2 Completed 60 enrolled Pfizer
RandomizedOpen-labelTreatment

Summary

The purpose of the study is to determine the safety and efficacy of 1% and 5% AN2690 solutions in the treatment of distal, subungual onychomycosis of the great toenail.

Timeline

Start
2006-06-30
Primary completion
2007-08-31
Completion
2007-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tavaborole Small molecule 1 % Topical
Subject Tavaborole Small molecule 5 % Topical

Indications